Clinical trial
Preventing Recurrence of Thromboembolic Events Through Coordinated Treatment in the District of Columbia
NCT00703274 is registered in ClinicalTrials.gov with Georgetown University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Preventing Recurrence of Thromboembolic Events Through Coordinated Treatment in the District of Columbia
- Lead sponsor
- Georgetown University
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- April 30, 2008
- Completion date
- January 31, 2013
- Enrollment
- 230 (actual)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.